Group 1 - The core viewpoint highlights that the technology sector is expected to see a rebound, particularly driven by the AI industry chain and improvements in domestic computing power [1] - The Biopharmaceutical sector, especially innovative drugs, has shown significant growth, with a 21% increase from July 1 to August 1, indicating a long-term positive trend [1] - The defense and military industry is anticipated to receive continuous stimulation ahead of the upcoming military parade on September 3 [1] Group 2 - The Guotai Science and Technology Innovation Index ETF (589630) has risen over 1.3%, reflecting the growing interest in the technology sector [1] - The index tracks approximately 97% of the market capitalization of the Science and Technology Innovation Board, focusing on strategic emerging industries such as new-generation information technology and biomedicine [1] - Investors without stock accounts can consider Guotai's linked ETFs, which provide access to the Science and Technology Innovation Board [1]
20cm速递|科创综指ETF国泰(589630)涨超1.3%,科技板块补涨动力受关注
Mei Ri Jing Ji Xin Wen·2025-08-11 03:56